pd 123177 has been researched along with nystatin a1 in 1 studies
| Studies (pd 123177) | Trials (pd 123177) | Recent Studies (post-2010) (pd 123177) | Studies (nystatin a1) | Trials (nystatin a1) | Recent Studies (post-2010) (nystatin a1) |
|---|---|---|---|---|---|
| 142 | 0 | 2 | 3,585 | 246 | 504 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, HC; Fu, LX; Law, SH; Leung, PS; Wong, PY | 1 |
1 other study(ies) available for pd 123177 and nystatin a1
| Article | Year |
|---|---|
Angiotensin II receptor type I-regulated anion secretion in cystic fibrosis pancreatic duct cells.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Angiotensin II; Angiotensin Receptor Antagonists; Antiporters; Bicarbonates; Biological Transport, Active; Biphenyl Compounds; Calcium; Cell Polarity; Cells, Cultured; Chloride-Bicarbonate Antiporters; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Imidazoles; Intracellular Fluid; Ion Transport; Losartan; Microscopy, Confocal; Nystatin; Pancreatic Ducts; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Secretory Rate; Tetrazoles | 1997 |